# A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

> **NCT04911751** · PHASE2 · COMPLETED · sponsor: **KoBioLabs** · enrollment: 80 (actual)

## Conditions studied

- Psoriatic Plaque

## Interventions

- **DRUG:** KBL697
- **DRUG:** KBL697

## Key facts

- **NCT ID:** NCT04911751
- **Lead sponsor:** KoBioLabs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-08
- **Primary completion:** 2023-11-08
- **Final completion:** 2024-10-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04911751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04911751, "A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04911751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*